ID   SGK2_HUMAN              Reviewed;         427 AA.
AC   Q9HBY8; Q52PK5; Q5H8Y6; Q5H8Z1; Q5TZR3; Q9UKG6;
DT   22-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 152.
DE   RecName: Full=Serine/threonine-protein kinase Sgk2;
DE            EC=2.7.11.1;
DE   AltName: Full=Serum/glucocorticoid-regulated kinase 2;
GN   Name=SGK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY,
RP   PHOSPHORYLATION AT THR-253, AND MUTAGENESIS OF SER-416.
RX   PubMed=10548550; DOI=10.1042/bj3440189;
RA   Kobayashi T., Deak M., Morrice N., Cohen P.;
RT   "Characterization of the structure and regulation of two novel
RT   isoforms of serum- and glucocorticoid-induced protein kinase.";
RL   Biochem. J. 344:189-197(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Li H., Nong W., Zhou G., Ke R., Shen C., Zhong G., Zheng Z., Liang M.,
RA   Xiao W., Lin L., Yang S.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION IN THE REGULATION OF NA(+)/K(+) ATPASE.
RX   PubMed=12590200; DOI=10.1159/000068699;
RA   Henke G., Setiawan I., Boehmer C., Lang F.;
RT   "Activation of Na+/K+-ATPase by the serum and glucocorticoid-dependent
RT   kinase isoforms.";
RL   Kidney Blood Press. Res. 25:370-374(2002).
RN   [7]
RP   FUNCTION.
RX   PubMed=12397388; DOI=10.1007/s00424-002-0873-2;
RA   Gamper N., Fillon S., Feng Y., Friedrich B., Lang P.A., Henke G.,
RA   Huber S.M., Kobayashi T., Cohen P., Lang F.;
RT   "K(+) channel activation by all three isoforms of serum- and
RT   glucocorticoid-dependent protein kinase SGK.";
RL   Pflugers Arch. 445:60-66(2002).
RN   [8]
RP   FUNCTION IN THE REGULATION OF KCNE1 AND KCNQ1.
RX   PubMed=12634932; DOI=10.1007/s00424-002-0982-y;
RA   Embark H.M., Boehmer C., Vallon V., Luft F., Lang F.;
RT   "Regulation of KCNE1-dependent K(+) current by the serum and
RT   glucocorticoid-inducible kinase (SGK) isoforms.";
RL   Pflugers Arch. 445:601-606(2003).
RN   [9]
RP   FUNCTION IN THE REGULATION OF SCNN1A/ENAC.
RX   PubMed=12632189; DOI=10.1007/s00424-002-0993-8;
RA   Friedrich B., Feng Y., Cohen P., Risler T., Vandewalle A., Broeer S.,
RA   Wang J., Pearce D., Lang F.;
RT   "The serine/threonine kinases SGK2 and SGK3 are potent stimulators of
RT   the epithelial Na+ channel alpha,beta,gamma-ENaC.";
RL   Pflugers Arch. 445:693-696(2003).
RN   [10]
RP   FUNCTION IN THE REGULATION OF KCNA3/KV1.3.
RX   PubMed=15040001; DOI=10.1002/jcp.10430;
RA   Henke G., Maier G., Wallisch S., Boehmer C., Lang F.;
RT   "Regulation of the voltage gated K+ channel Kv1.3 by the ubiquitin
RT   ligase Nedd4-2 and the serum and glucocorticoid inducible kinase
RT   SGK1.";
RL   J. Cell. Physiol. 199:194-199(2004).
RN   [11]
RP   FUNCTION IN THE REGULATION OF SLC6A19.
RX   PubMed=20511718; DOI=10.1159/000315092;
RA   Boehmer C., Sopjani M., Klaus F., Lindner R., Laufer J., Jeyaraj S.,
RA   Lang F., Palmada M.;
RT   "The serum and glucocorticoid inducible kinases SGK1-3 stimulate the
RT   neutral amino acid transporter SLC6A19.";
RL   Cell. Physiol. Biochem. 25:723-732(2010).
RN   [12]
RP   FUNCTION IN THE REGULATION OF SLC9A3/NHE3, AND SUBCELLULAR LOCATION.
RX   PubMed=21865597; DOI=10.1091/mbc.E11-04-0328;
RA   He P., Lee S.J., Lin S., Seidler U., Lang F., Fejes-Toth G.,
RA   Naray-Fejes-Toth A., Yun C.C.;
RT   "Serum- and glucocorticoid-induced kinase 3 in recycling endosomes
RT   mediates acute activation of Na+/H+ exchanger NHE3 by
RT   glucocorticoids.";
RL   Mol. Biol. Cell 22:3812-3825(2011).
RN   [13]
RP   REVIEW.
RX   PubMed=16460280; DOI=10.1146/annurev.physiol.68.040104.131654;
RA   Loffing J., Flores S.Y., Staub O.;
RT   "Sgk kinases and their role in epithelial transport.";
RL   Annu. Rev. Physiol. 68:461-490(2006).
RN   [14]
RP   REVIEW ON FUNCTION.
RX   PubMed=20919962; DOI=10.3109/08977194.2010.518616;
RA   Bruhn M.A., Pearson R.B., Hannan R.D., Sheppard K.E.;
RT   "Second AKT: the rise of SGK in cancer signalling.";
RL   Growth Factors 28:394-408(2010).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-12; LYS-259 AND TYR-349.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase which is involved in the
CC       regulation of a wide variety of ion channels, membrane
CC       transporters, cell growth, survival and proliferation. Up-
CC       regulates Na(+) channels: SCNN1A/ENAC, K(+) channels: KCNA3/Kv1.3,
CC       KCNE1 and KCNQ1, amino acid transporter: SLC6A19, glutamate
CC       transporter: SLC1A6/EAAT4, glutamate receptors: GRIA1/GLUR1 and
CC       GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+)
CC       ATPase. {ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200,
CC       ECO:0000269|PubMed:12632189, ECO:0000269|PubMed:12634932,
CC       ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:20511718,
CC       ECO:0000269|PubMed:21865597}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Two specific sites, one in the kinase domain
CC       (Thr-253) and the other in the C-terminal regulatory region (Ser-
CC       416), need to be phosphorylated for its full activation.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21865597}.
CC       Nucleus {ECO:0000269|PubMed:21865597}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=2; Synonyms=beta;
CC         IsoId=Q9HBY8-1; Sequence=Displayed;
CC       Name=1; Synonyms=alpha;
CC         IsoId=Q9HBY8-2; Sequence=VSP_004932;
CC       Name=3;
CC         IsoId=Q9HBY8-3; Sequence=VSP_026682;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver, kidney and
CC       pancreas, and at lower levels in brain.
CC       {ECO:0000269|PubMed:10548550}.
CC   -!- PTM: Activated by phosphorylation on Ser-416 by an unknown kinase
CC       (may be mTORC2 but not confirmed), transforming it into a
CC       substrate for PDPK1 which then phosphorylates it on Thr-253.
CC       {ECO:0000269|PubMed:10548550}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- CAUTION: Not regulated by serum or glucocorticoids. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF169034; AAF12757.2; -; mRNA.
DR   EMBL; AF186470; AAG17012.1; -; mRNA.
DR   EMBL; AY987010; AAX88805.1; -; mRNA.
DR   EMBL; BT020098; AAV38901.1; -; mRNA.
DR   EMBL; Z98752; CAC18509.1; -; Genomic_DNA.
DR   EMBL; Z98752; CAI42312.1; -; Genomic_DNA.
DR   EMBL; Z98752; CAI42315.1; -; Genomic_DNA.
DR   EMBL; BC014037; AAH14037.3; -; mRNA.
DR   EMBL; BC065511; AAH65511.1; -; mRNA.
DR   CCDS; CCDS13320.1; -. [Q9HBY8-1]
DR   CCDS; CCDS13321.1; -. [Q9HBY8-2]
DR   RefSeq; NP_001186193.1; NM_001199264.1. [Q9HBY8-2]
DR   RefSeq; NP_057360.2; NM_016276.3. [Q9HBY8-1]
DR   RefSeq; NP_733794.1; NM_170693.2. [Q9HBY8-2]
DR   UniGene; Hs.300863; -.
DR   UniGene; Hs.740147; -.
DR   ProteinModelPortal; Q9HBY8; -.
DR   SMR; Q9HBY8; -.
DR   BioGrid; 115416; 16.
DR   IntAct; Q9HBY8; 14.
DR   STRING; 9606.ENSP00000340608; -.
DR   BindingDB; Q9HBY8; -.
DR   ChEMBL; CHEMBL5794; -.
DR   GuidetoPHARMACOLOGY; 1535; -.
DR   iPTMnet; Q9HBY8; -.
DR   PhosphoSitePlus; Q9HBY8; -.
DR   BioMuta; SGK2; -.
DR   DMDM; 28558166; -.
DR   MaxQB; Q9HBY8; -.
DR   PaxDb; Q9HBY8; -.
DR   PeptideAtlas; Q9HBY8; -.
DR   PRIDE; Q9HBY8; -.
DR   DNASU; 10110; -.
DR   Ensembl; ENST00000341458; ENSP00000340608; ENSG00000101049. [Q9HBY8-1]
DR   Ensembl; ENST00000373092; ENSP00000362184; ENSG00000101049. [Q9HBY8-2]
DR   Ensembl; ENST00000373100; ENSP00000362192; ENSG00000101049. [Q9HBY8-2]
DR   Ensembl; ENST00000423407; ENSP00000392795; ENSG00000101049. [Q9HBY8-2]
DR   Ensembl; ENST00000426287; ENSP00000412214; ENSG00000101049. [Q9HBY8-3]
DR   GeneID; 10110; -.
DR   KEGG; hsa:10110; -.
DR   UCSC; uc002xkr.4; human. [Q9HBY8-1]
DR   CTD; 10110; -.
DR   DisGeNET; 10110; -.
DR   GeneCards; SGK2; -.
DR   H-InvDB; HIX0080189; -.
DR   HGNC; HGNC:13900; SGK2.
DR   HPA; HPA008859; -.
DR   HPA; HPA011387; -.
DR   MIM; 607589; gene.
DR   neXtProt; NX_Q9HBY8; -.
DR   OpenTargets; ENSG00000101049; -.
DR   PharmGKB; PA37824; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   eggNOG; ENOG410XNPH; LUCA.
DR   GeneTree; ENSGT00860000133668; -.
DR   HOGENOM; HOG000233033; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; Q9HBY8; -.
DR   KO; K13303; -.
DR   OrthoDB; EOG091G06FF; -.
DR   PhylomeDB; Q9HBY8; -.
DR   TreeFam; TF320906; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   SignaLink; Q9HBY8; -.
DR   SIGNOR; Q9HBY8; -.
DR   GeneWiki; SGK2; -.
DR   GenomeRNAi; 10110; -.
DR   PRO; PR:Q9HBY8; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000101049; -.
DR   CleanEx; HS_SGK2; -.
DR   ExpressionAtlas; Q9HBY8; baseline and differential.
DR   Genevisible; Q9HBY8; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005622; C:intracellular; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005246; F:calcium channel regulator activity; IBA:GO_Central.
DR   GO; GO:0017081; F:chloride channel regulator activity; IBA:GO_Central.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0017080; F:sodium channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0032411; P:positive regulation of transporter activity; TAS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0001558; P:regulation of cell growth; TAS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    427       Serine/threonine-protein kinase Sgk2.
FT                                /FTId=PRO_0000086646.
FT   DOMAIN       95    352       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      353    427       AGC-kinase C-terminal.
FT   NP_BIND     101    109       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       128    138       Nuclear localization signal.
FT                                {ECO:0000250}.
FT   ACT_SITE    219    219       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     124    124       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      70     70       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8R4U9}.
FT   MOD_RES     253    253       Phosphothreonine; by PDPK1.
FT                                {ECO:0000269|PubMed:10548550}.
FT   MOD_RES     416    416       Phosphoserine. {ECO:0000255}.
FT   VAR_SEQ       1     60       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:10548550,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_004932.
FT   VAR_SEQ      19     52       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_026682.
FT   VARIANT      12     12       S -> T (in dbSNP:rs33969356).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041073.
FT   VARIANT     259    259       E -> K (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041074.
FT   VARIANT     349    349       H -> Y (in dbSNP:rs35793869).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041075.
FT   MUTAGEN     416    416       S->D: Increased activation.
FT                                {ECO:0000269|PubMed:10548550}.
FT   CONFLICT    137    137       Missing (in Ref. 4; CAI42315).
FT                                {ECO:0000305}.
FT   CONFLICT    168    168       K -> E (in Ref. 2; AAX88805).
FT                                {ECO:0000305}.
FT   CONFLICT    208    208       G -> D (in Ref. 3; AAV38901).
FT                                {ECO:0000305}.
FT   CONFLICT    337    337       L -> P (in Ref. 2; AAX88805).
FT                                {ECO:0000305}.
SQ   SEQUENCE   427 AA;  47604 MW;  D8F0FA6DF54B1370 CRC64;
     MQGLLTSGRK PSGGGRCTGR GGWRGQWCLK PWMGGADPPT PTLSCLLLPV PPELPDHCYR
     MNSSPAGTPS PQPSRANGNI NLGPSANPNA QPTDFDFLKV IGKGNYGKVL LAKRKSDGAF
     YAVKVLQKKS ILKKKEQSHI MAERSVLLKN VRHPFLVGLR YSFQTPEKLY FVLDYVNGGE
     LFFHLQRERR FLEPRARFYA AEVASAIGYL HSLNIIYRDL KPENILLDCQ GHVVLTDFGL
     CKEGVEPEDT TSTFCGTPEY LAPEVLRKEP YDRAVDWWCL GAVLYEMLHG LPPFYSQDVS
     QMYENILHQP LQIPGGRTVA ACDLLQSLLH KDQRQRLGSK ADFLEIKNHV FFSPINWDDL
     YHKRLTPPFN PNVTGPADLK HFDPEFTQEA VSKSIGCTPD TVASSSGASS AFLGFSYAPE
     DDDILDC
//
